AMERICAN VANGUARD CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AMERICAN VANGUARD CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	312	355	454	468	459	558	610	579	547	515
Cost of revenue	184	208	272	291	286	387	417	400	427	368
Gross profit	128	147	183	177	173	171	192	179	120	148
Research and development	21.3	26.1	26.4	24.1	26.3	28.9	31.8	38	32.7	23.2
Selling, general and administrative						111	120	117	120	111
General and administrative	32.1	37.7	43	46.6	36.1	48	51.7
Operating expenses	108	121	144	151	154	183	10.8	12.3	10.9	8.89
Operating income	20.5	26.8	39	26.2	22.9	30.9	40.7	23.3	-102	-28.3
Interest expense	1.62	1.94	4.02	7.21	5.18	3.69	3.95	12.6	16.5	18.5
Pre-tax income	18.9	24.9	33.6	19	18.4	27.1	36	10.3	-120	-47.2
Income tax	5.54	4.44	9.15	5.2	3.08	8.17	8.56	2.78	5.88	2.68
Net income to minority interests	0.24	0.09	-0.13
Net income	12.8	20.3	24.2	13.6	15.2	18.6	27.4	7.52	-126	-49.9
EBITDA	36.9	43.8	57.9	44.9	42.8	40.2	49.6	29.9	-96.4	-23
EPS, basic	0.44	0.70	0.83	0.47	0.52	0.62	0.94	0.27	-4.50	-1.75
EPS, diluted	0.44	0.68	0.81	0.46	0.51	0.61	0.92	0.26	-4.50	-1.75
Shares, basic (weighted)	28.9	29.1	29.3	29	29.5	29.8	29.2	28.1	28.1	28.4
Shares, diluted (weighted)	29.4	29.7	30	29.7	30	30.4	29.9	28.5	28.1	28.4
Dividend per share	0.03	0.06	0.08	0.08	0.04	0.08	0.10	0.12	0.06

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	7.87	11.3	6.17	6.58	15.9	16.3	20.3	11.4	12.5	12.4
Receivables	83.8	103	123	136	130	149	156	183	170	161
Inventory	121	123	160	163	164	154	184	220	179	176
Other current assets	11.4	10.8	10.1	10.5	10.5	12.5	15.9	6.26	7.62	9.67
Total current assets	227	255	310	336	330	342	389	432	379	371
Property, plant and equipment	50.3	49.3	49.3	56.5	65.4	66.1	70.9	74.6	58.2	53
Lease right-of-use assets				11.3	12.2	25.4	24.3	22.4	19.7	16.8
Goodwill		22.3	25.9	46.7	52.1	46.3	47	51.2	19.7	0
Intangible assets	121	181	187	198	198	198	185	173	150	139
Other non-current assets	31.2	28.3	21.8	21.2	20.1	16.3	10.8	12	8.48	14.8
Total assets	430	536	594	670	680	694	726	768	637	597
Accounts payable	24.4	53.7	66.5	64.9	59.3	67.1	69	68.8	69.2	87.5
Accrued liabilities	42.9	39.1	37.3	47.7	45.4	63.2	60.7	68.1	69.4	52.2
Deferred revenue	3.85	14.6	20	6.83	43.6	63.1
Short-term debt	0	0	0	0	0	0	0	0	0	0
Total current liabilities	97.1	126	146	139	171	223	267	230	232	209
Long-term debt	41	77.5	96.7	149	107	52.2	51.5	139	147	174
Lease liabilities				6.5	8.18	20.8	19.5	17.1	14.3	11.6
Other non-current liabilities	2.87	10.3	6.8	12.9	9.05	5.34	4.17	3.14	1.6	0.92
Total liabilities	148	230	264	326	320	321	356	398	404	404
Total debt	41	77.5	96.7	149	107	52.2	51.5	139	147	174
Paid-in capital	71.7	75.7	83.2	90.6	96.6	101	106	111	115	117
Retained earnings	220	239	263	274	288	304	329	333	205	155
Treasury stock	-8.27	-8.27	-15.6	-18.2	-18.2	-22.7	-55.7	-71.2	-71.2	-71.2
Other comprehensive income	-4.85	-4.51	-4.51	-5.7	-9.32	-13.8	-12.2	-5.96	-18.7	-12
Shareholders' equity	282	305	329
Minority interests	0.17	0.25
Total equity	282	305	329	344	361	373	370	370	233	192
Total liabilities and equity	430	536	594	670	680	694	726	768	637	597

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	13	20.4	24.1	13.6	15.2	18.6	27.4	7.52	-126	-49.9
Depreciation and amortization	16.3	17	18.9	18.6	19.9	9.23	8.91	6.6	5.16	5.26
Stock-based compensation	3.17	4.71	5.81	7.16	6.56	6.88	5.68	6.14	4.41	2.02
Deferred income tax	-0.15	0.4	-0.56	2.62	0.97	-2.09	-5.28	-9.71	1.45	-1.35
Change in receivables	-11.8	0.75	-22.5	-11.5	15.4	-24.3	-6.45	-20.3	7.48	7.7
Change in inventory	15.9	16.2	-31.4	3.82	6.68	9.36	-29.2	-27.3	35.2	6.29
Change in payables	9.02	3.32	9.1	-7.91	-8.2	8.78	1.7	-2.29	3.71	15.4
Cash from operations	46.4	59	11.7	9.61	90.3	86.4	57.1	-58.7	3.92	-21.2
Capital expenditures	-10.6	-6.67	-8.05	-13	-11.2	-9.52	-13.3	-11.9	-7.28	-3.92
Acquisitions	-0.22	-81.9	-20	-38	-19.3	-10	0	-5.2	0	0
Cash from investing	-14.1	-89.5	-28	-54.8	-35.8	-20	-14.5	-17	-6.62	-3.61
Stock issued	0.24
Share buybacks			-7.29	-2.6	0	-4.58	-34	-15.5	0	0
Dividends paid	-0.58	-1.6	-2.2	-2.32	-1.17	-2.38	-2.79	-3.38	-2.51	0
Cash from financing	-28.5	33.9	11.1	46.4	-44.4	-65.9	-38.3	66.7	4.54	23.7
Exchange rate effect	-1.38	0.04	0.05
Net change in cash	3.72	3.42	-5.22	1.18	10.1	0.45	4.38	-9.03	1.84	-1.09
Free cash flow	35.8	52.3	3.61	-3.37	79.1	76.8	43.8	-70.6	-3.36	-25.1
Interest paid	1.75	1.5	3.32	7.12	5.31	3.52	3.83	11.9	15.6	16.8
Income taxes paid	4.95	17.8	8.45	9.28	3.88	5.8	20	9.43	8.76	3.94

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.87 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	29.4%	Gross profit / revenue.
Operating margin	-5.2%	Operating income / revenue.
EBITDA margin	-2.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-10.3%	Pre-tax income / revenue.
Net margin	-10.7%	Net income / revenue.
FCF margin	-9.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	-8.2%	Cash from operations / revenue.
Return on assets (ROA)	-8.6%	Net income / average total assets.
R&D / revenue	4.6%	Research and development expense / revenue.
SG&A / revenue	21.5%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.0%	Capital expenditures / revenue.
D&A / revenue	2.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-5.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-5.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	2.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	22.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-8.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-3.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-640.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y	-6.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-6.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-2.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.47x	Current assets / current liabilities.
Quick ratio	1.29x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.26x	(Cash + short-term investments) / current liabilities.
Debt / assets	42.1%	Total debt / total assets.
Liabilities / assets	71.5%	Total liabilities / total assets.
Net debt	$223.7M	Total debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage	-1.06x	Operating income / interest expense.
Working capital	$249.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	21.0%	(Goodwill + intangible assets) / total assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.80x	Revenue / average total assets.
Fixed asset turnover	9.97x	Revenue / average property, plant and equipment.
Inventory turnover	1.99x	Cost of revenue / average inventory.
Days inventory	184 days	365 x average inventory / cost of revenue.
Receivables turnover	2.92x	Revenue / average receivables.
Days sales outstanding	125 days	365 x average receivables / revenue.
Days payables	88 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	220 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$1.91	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$17.81	Revenue / diluted weighted shares.
FCF per share	-$1.64	Free cash flow / diluted weighted shares.
Operating cash flow per share	-$1.46	Cash from operations / diluted weighted shares.
Cash per share	$1.53	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$55.2M	Share price x shares outstanding.
Enterprise value	$278.9M	Market cap + total debt - cash - short-term investments.
P/S	0.11x	Market cap / revenue.
EV/Sales	0.55x	Enterprise value / revenue.
FCF yield	-85.3%	Free cash flow / market cap.
Earnings yield	-98.9%	Net income / market cap (the inverse of P/E).

What was AMERICAN VANGUARD CORP's revenue in fiscal 2025?

AMERICAN VANGUARD CORP reported revenue of $515.1M for fiscal 2025, 5.9% lower than the year before.

Was AMERICAN VANGUARD CORP profitable in fiscal 2025?

No. It reported a net loss of $49.9M.

How much free cash flow did AMERICAN VANGUARD CORP generate in fiscal 2025?

Cash from operations of $21.2M minus capital expenditures of $3.9M left free cash flow of -$25.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to AMERICAN VANGUARD CORP